MD Anderson Study Highlights Risks of Delayed Chemotherapy in Breast Cancer …

MD Anderson Study Highlights Risks of Delayed Chemotherapy in Breast Cancer …

To clarify the treatment's optimal timing and identify factors that may contribute to a delay, the research team analyzed data from the California Cancer Registry comprising 24,823 patients with stage 1 to 3 invasive breast cancer, diagnosed between Jan.

(Visited 4 times, 1 visits today)
4
Like
Save

Comments

Comments are disabled for this post.